Home › Funds › NWI MANAGEMENT LP › ALLO

NWI MANAGEMENT LP position in ALLO

ALLOGENE THERAPEUTICS INC · Health Care

NWI MANAGEMENT LP reported holding 100,000 shares of ALLO (ALLOGENE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$208K, representing 0.01% of its reported portfolio and ranking #50 among its reported holdings. NWI MANAGEMENT LP has disclosed ALLO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)100.00K sh
Reported value held$208.00K
Portfolio Weight0.01%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How NWI MANAGEMENT LP's ALLO position evolved

NWI MANAGEMENT LP first disclosed a stake in ALLO in Q2 2025 at 100,000 shares (US$113K). The position peaked in Q1 2026 at 100,000 shares, worth US$244K. Across 5 filings, NWI MANAGEMENT LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 100,000 shares valued at US$208K.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 100.00K $113.00K New
Q3 2025 100.00K $124.00K Hold
Q4 2025 100.00K $137.00K Hold
Q1 2026 100.00K $244.00K Hold
Q2 2026 100.00K $208.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALLO and 13F data

ALLO (ALLOGENE THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in ALLO — the largest reported positions include PFIZER INC (US$46.9M), Frazier Life Sciences Management, L.P. (US$46.7M), TPG GP A, LLC (US$38.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALLO

All ALLO fund holders →

FAQ

How long has NWI MANAGEMENT LP held ALLO?

NWI MANAGEMENT LP has disclosed ALLO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is NWI MANAGEMENT LP's current position in ALLO?

As of Q2 2026, NWI MANAGEMENT LP holds 100.00K shares of ALLO (ALLOGENE THERAPEUTICS INC), valued at $208.00K, representing 0.01% of its reported portfolio and ranking #50.

Has NWI MANAGEMENT LP been buying or selling ALLO?

In the latest 13F filing (Q2 2026), NWI MANAGEMENT LP held unchanged its position in ALLO. The position peaked in Q1 2026 at 100.00K shares.

Which other funds hold ALLO?

Other major institutional holders of ALLO include PFIZER INC, Frazier Life Sciences Management, L.P., TPG GP A, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.